SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 172 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $422,000 | -13.0% | 56,330 | +4.6% | 0.03% | -22.0% |
| Q3 2021 | $485,000 | -26.0% | 53,830 | -1.6% | 0.04% | -25.5% |
| Q2 2021 | $655,000 | +388.8% | 54,710 | +410.8% | 0.06% | +358.3% |
| Q1 2021 | $134,000 | -32.7% | 10,710 | -16.2% | 0.01% | -36.8% |
| Q4 2020 | $199,000 | +64.5% | 12,780 | 0.0% | 0.02% | +46.2% |
| Q3 2020 | $121,000 | -64.3% | 12,780 | -66.2% | 0.01% | -67.5% |
| Q2 2020 | $339,000 | +40.7% | 37,780 | 0.0% | 0.04% | +14.3% |
| Q1 2020 | $241,000 | +125.2% | 37,780 | +195.6% | 0.04% | +169.2% |
| Q4 2019 | $107,000 | -7.8% | 12,780 | 0.0% | 0.01% | -13.3% |
| Q3 2019 | $116,000 | -15.9% | 12,780 | 0.0% | 0.02% | -16.7% |
| Q2 2019 | $138,000 | +21.1% | 12,780 | +7.4% | 0.02% | +12.5% |
| Q1 2019 | $114,000 | -16.8% | 11,900 | 0.0% | 0.02% | -27.3% |
| Q4 2018 | $137,000 | -80.2% | 11,900 | -70.9% | 0.02% | -76.6% |
| Q3 2018 | $693,000 | +17.9% | 40,900 | -1.2% | 0.09% | +9.3% |
| Q2 2018 | $588,000 | -23.4% | 41,400 | +2.5% | 0.09% | -25.2% |
| Q1 2018 | $768,000 | +1.3% | 40,400 | -12.6% | 0.12% | +1.8% |
| Q4 2017 | $758,000 | -10.6% | 46,200 | -18.2% | 0.11% | -18.7% |
| Q3 2017 | $848,000 | +70.6% | 56,500 | 0.0% | 0.14% | +63.5% |
| Q2 2017 | $497,000 | +24.9% | 56,500 | -26.1% | 0.08% | +21.4% |
| Q1 2017 | $398,000 | +680.4% | 76,500 | +595.5% | 0.07% | +677.8% |
| Q3 2016 | $51,000 | -83.5% | 11,000 | -79.4% | 0.01% | -84.7% |
| Q2 2016 | $310,000 | -4.3% | 53,500 | 0.0% | 0.06% | -7.8% |
| Q1 2016 | $324,000 | -33.7% | 53,500 | 0.0% | 0.06% | -33.3% |
| Q4 2015 | $489,000 | +54.7% | 53,500 | -4.5% | 0.10% | +52.4% |
| Q3 2015 | $316,000 | -49.1% | 56,000 | 0.0% | 0.06% | -43.2% |
| Q2 2015 | $621,000 | -29.3% | 56,000 | 0.0% | 0.11% | -31.1% |
| Q1 2015 | $878,000 | -32.9% | 56,000 | -34.9% | 0.16% | -35.3% |
| Q4 2014 | $1,308,000 | +40.9% | 86,000 | 0.0% | 0.25% | +41.5% |
| Q3 2014 | $928,000 | -42.0% | 86,000 | -17.9% | 0.18% | -42.3% |
| Q2 2014 | $1,599,000 | -39.3% | 104,750 | -28.1% | 0.30% | -42.1% |
| Q1 2014 | $2,633,000 | +30.7% | 145,650 | +0.4% | 0.53% | +29.5% |
| Q4 2013 | $2,014,000 | +28.2% | 145,000 | -3.2% | 0.41% | +15.6% |
| Q3 2013 | $1,571,000 | +65.2% | 149,800 | +23.0% | 0.35% | +51.1% |
| Q2 2013 | $951,000 | – | 121,800 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |